Evaluating the prognostic utility of cell-free (cf)DNA tumor fraction (TF) in metastatic castration-resistant prostate cancer (mCRPC).

Authors: Daniel Boiarsky, Razane El Hajj Chehade, Hunter Savignano, Katelyn Kuczmarski, Rachel Trowbridge, Gwo-Shu Mary Lee, Caroline Weipert, Haiyang Zhang, Atish Dipankar Choudhury, Alok Tewari, Jacob E Berchuck

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.5052

Source: Full article

---

Abstract

5052